期刊文献+

蛋白酶体抑制剂DCI对胃癌细胞P38α信号的调节 被引量:1

Relationship between the expression of P38α and apoptosis of cells BGC823 induced by DCI
暂未订购
导出
摘要 目的探讨P3 8α在蛋白酶体抑制剂3,4-二氯异香豆素(3,4-Dichloroisocoumarin,DCI)诱导人胃癌细胞BGC8 2 3凋亡过程中作用。方法采用MTT,流式细胞术、分析DCI对细胞凋亡的诱导作用,RT-PCR分析DCI作用于胃癌细胞后P3 8 MAPK在基因表达水平改变的情况。结果随着DIC浓度的增加和处理时间延长,胃癌细胞增殖明显受到抑制,4 0 0μmol.L?1DCI作用于胃癌细胞2 4 h后细胞存活率4 3.6±5.3%,与对照组比较差异显著(P(0.0 1)。流式细胞术显示DCI主要作用于S期细胞,3 0 0μmol.L?1DCI浓度时,细胞凋亡率2 3.8 6%,与对照组比较差异明显(P(0.0 5)。3 0 0、1 5 0μmol.L?1DCI作用于胃癌细胞后均可以使P3 8α基因灰度值明显高于对照组,差异有显著性(P(0.0 1)。结论DCI可抑制人胃癌BGC8 2 3细胞增殖并促进其凋亡,在此过程中P3 8α通路激活发挥重要作用。 Objective To explore relationship between the expression of P38a and apoptosis of cells BGC823 induced by DCI(3,4-Dichloroisocoumarin). Methods MTT assay was used to calculate the cell inhibition rate ,AnnexinV / PI staining was used to determine the apoptosis rate. The expression of P38a was determined by RT-PCR. Results DCI inhibited BGC823 cell growth significantly with the raised concentration and prolonged treatment of DCL The survival rate of BGC- 823was 43.6±5.3% after treating by 400μmol · L^-1 DCI. There was significant differences comparing with control group. Flow cytometric analysis display that DCI have an effect on the S stage cell. The apoptosis rate of group DCI (300 μmol· L^-1 )was significant,which was reached to 23.86% . There were significant differences between group DCI and control group (P 〈 0.01). The expression of P38 gene is higher in group DCI (300μmol · L^- 1and 150μmol · L^-1 ) than that of the control group(P 〈 0.01). Conclusions DCI can significantly inhibit prolification of BGC823 cells in vitro and induce them injury and apoptosis. High expression of P38a gene caused by DCI were related to cells' injury and apoptosis.
作者 费正华 姜藻
出处 《实用肿瘤学杂志》 CAS 2008年第4期322-325,共4页 Practical Oncology Journal
关键词 胃癌 蛋白酶体抑制剂 P38 Gastric neoplasms Proteasome inhibitors P38
  • 相关文献

参考文献20

  • 1Asams J. The proteasome: structure, function, and role in the cell[J]. Cancer Treat Rev,2003,29 : 3-9
  • 2Podar K, Gouill SL, Zhang J, et al. A pivotal role for Mcl-1 in Bortezomib-induced apoptosis[J]. Oncogene, 2008, 27(6) :721-731
  • 3Kim OH , Li JH, Woo KJ, et al. Influence of p53 and p21Waf1 expression on G2/M phase arerest of colorectal carcinoma HCT116 cells to proteasome inhibitors[J]. Int J Oncol,2004,24(4) :935-941
  • 4林如峰,陆化,沈文怡,刘澎,王永韧,汪承亚,李建勇.蛋白酶体抑制剂PS-341对多发性骨髓瘤间充质干细胞IL-1β表达的影响[J].江苏医药,2006,32(4):337-339. 被引量:3
  • 5Gotoh A,Ohyashiki K. Role of bortezomib in the treatment of multiple myeloma[J].Journal of Clinical Medicine,2007,65(12) :2309-14
  • 6Voorhees PM, Dees EC, O'NeilB, et al. The proteasome as a target for cancer therapy[J]. Clin Cancer Res, 2003, 9:6316-6325
  • 7Concannon CG, Koehler BF, Reimertz, et al. Apoptosis induced by proteasome inhibition in cancer cells: predominant role of the p53/PUMA pathway[J].Oncogene, 2007,26(12) :1681-1692
  • 8Denny JB. Growth-associated protein of 43 kDa (GAP- 43)is cleavednonprocessively by the 20S proteasome[J]. Eur J Biochem, 2004,271 : 2480-2493
  • 9Reidlinger J, Pike AM, Savory PJ,et al. Catalytic Properties of 26S and 20 S Proteasomes and Radiolabeling of MB1,LMPT,and C7 Subunits Associated with Trypsinlike and Chymotrypsin-like Activities[J].The Journal Of Biological Chemistry, 1997,272 : 24899-248905
  • 10Rew DA, Wilson GD. Cell production rates in human tissues and tumours and their significance. Part Ⅱ:clinical data[J]. Eur J Surg Oncol, 2000,26 : 405 -417

二级参考文献43

共引文献44

同被引文献16

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部